➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Colorcon
Medtronic
Baxter
McKinsey

Last Updated: July 28, 2021

DrugPatentWatch Database Preview

Patent: 10,017,762

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,017,762
Title:Compositions and methods for treating or preventing lupus
Abstract: The present disclosure provides methods for inhibiting and/or reducing self-reactive IgE and/or basophils, thereby treating or preventing lupus, lupus nephritis, and lupus-related disorders.
Inventor(s): Rivera; Juan (Mechanicsburg, PA), Charles; Nicolas (Asnieres sur Seine, FR)
Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC)
Application Number:15/498,202
Patent Claims:see list of patent claims

Details for Patent 10,017,762

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22 ⤷  Free Forever Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) 2039-02-26 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22 ⤷  Free Forever Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) 2039-02-26 RX Orphan search
Glaxosmithkline Llc BENLYSTA belimumab INJECTABLE;INJECTION 761043 001 2017-07-20 ⤷  Free Forever Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) 2039-02-26 RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 002 2011-03-09 ⤷  Free Forever Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) 2039-02-26 RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ⤷  Free Forever Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) 2039-02-26 RX search
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 002 1997-11-26 ⤷  Free Forever Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) 2039-02-26 RX search
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 001 1997-11-26 ⤷  Free Forever Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,017,762

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2012071042 ⤷  Free Forever Trial
United States of America 10907151 ⤷  Free Forever Trial
United States of America 2014127199 ⤷  Free Forever Trial
United States of America 2017275617 ⤷  Free Forever Trial
United States of America 2018320174 ⤷  Free Forever Trial
United States of America 9657292 ⤷  Free Forever Trial
South Korea 101813482 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
McKinsey
McKesson
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.